Fr!ska is an innovative food supplement that combines probiotics, botanicals, and Enzymes.
KYBORA identified the acquisition opportunity, presented it to Megalabs, and lead the process that resulted in the acquisition.
The agreement demonstrates KYBORA’s ability to drive cross borders merger and acquisition transactions in the US OTC space and deliver value added services to global clients.
To learn more about our M&A services, please click here.
20 years of experience in international business development in the pharmaceutical industry. Head of commercial operations and business development for Bristol-Myers Squibb in 16 Latin American countries. Global management consultant. Speaks French and Spanish fluently. Completed nine transactions in global markets in the past three years.
